NIH-funded research R01 grant

Improving heart function through a new approach to cardiac muscle contraction

Official title: Troponin I phosphorylation as a novel novel cardiac inotrope

Funded at Ohio State University · NIH-11052653 · Data updated 2026-11-12

This study is looking at a new way to help people with heart disease by focusing on a protein called troponin I, aiming to improve heart function without the side effects that come from traditional treatments, and it could lead to safer options for patients like you.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2025
Award (this year)$567,962
NIH project number5R01HL164795-03
Project IDNIH-11052653 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with heart disease who experience insufficient heart function.

Less likely to help

Patients with non-cardiac related conditions or those whose heart function is not compromised may not benefit from this research.

What this research studies

This research investigates a novel method to enhance heart function in patients with heart disease by focusing on the protein troponin I. Unlike traditional treatments that increase calcium levels and can lead to harmful side effects, this approach aims to phosphorylate troponin I to improve heart contractions without raising calcium levels. The study will explore how this phosphorylation can enhance cardiac function in both healthy and diseased hearts, using mouse models and human cardiac tissue. The goal is to develop a safer therapeutic option for patients suffering from heart conditions.

Why it matters

Potential benefit: If successful, this research could lead to a new treatment that improves heart function without the adverse effects associated with current therapies.

How similar studies have gone: Previous research has shown promise in targeting troponin I for cardiac function improvement, suggesting potential for success in this novel approach.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Biesiadecki, Brandon J — Ohio State University
  • Study coordinator: Biesiadecki, Brandon J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.